Tarvacin, instead of a big red flag some of us a big green light. With a little more positive news maybe Peregrine can vault up to the 2 billion dollar level. Maybe BMY will want to use Bavi to pave the way for its immunotherapies, approved and in their pipeline. I know a buyout at this level would be unacceptable to many here, but 2 billion in the hand is worth 10 billion in the bush.
News 
Market Data 
Discover 
AI
